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We analyzed 90 nonduplicates community-associated methicillin-resistant S. aureus (CA-MRSA) strains isolated from skin and
soft-tissue infections. All strains were mecA positive. Twenty-four of the 90 strains showed inducible macrolide-lincosamide-
streptogramin B resistance. All strains produced α-toxin; 96% and 100% of them displayed positive results for lukS-F and cna
genes, respectively. Eigthy-ﬁve strains expressed capsular polysaccharide serotype 8. Six diﬀerent pulsotypes were discriminated
by pulsed-ﬁeld gel electrophoresis (PFGE) and three predominant groups of CA-MRSA strains (1, 2, and 4) were identiﬁed, in
agreementwithphenotypicandgenotypiccharacteristics.Strainsofgroup1(pulsotypeA,CP8+,andPanton-Valentineleukocidin
(PVL)+) were the most frequently recovered and exhibited a PFGE band pattern identical to other CA-MRSA strains previously
isolated in Uruguay and Brazil. Three years after the ﬁrst local CA-MRSA report, these strains are still producing skin and soft-
tissue infections demonstrating the stability over time of this community-associated emerging pathogen.
Copyright © 2009 Lorena Pardo et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Staphylococcus aureus is capable of establishing a wide spec-
trum of interactions with the human host. It can be part of
themicrobialﬂoraorcauseavarietyofillnessesrangingfrom
mild infections compromising skin and soft-tissues to severe
life-threateningdiseasessuchasnecrotizingpneumonia,bac-
teremia,osteomyelitis,toxicshocksyndrome,andmeningitis
[1]. S. aureus harbors several virulence factors including
surface-associated adhesins, secreted exo-proteins and toxins
[2–5]. Another important characteristic of S. aureus is the
capacity to acquire resistance to antimicrobial agents. The
ﬁrst isolation of methicillin-resistant S. aureus (MRSA) was
reported in 1960 and since then the prevalence of MRSA
has increased in all scrutinized regions, with diﬀerent ﬁgures
even within the same country [6, 7]. Methicillin resistance
is conferred by the mecA gene which codes for an additional
penicillin-binding protein, namely, 2a (PBP2a) with reduced
aﬃnity to β-lactam agents. This gene is located in a mobile
genetic element of variable size called staphylococcal cassette
chromosome mec (SCCmec). So far, seven types and several
subtypes of SCCmec have been characterized [8–11].
Since 1990 an increasing number of cases pro-
duced by MRSA acquired in the community have been
reported, especially in children and young adults without
the classical risk factors involved in healthcare-associated
methicillin-resistant S. aureus (HA-MRSA) infections [12–
15]. These strains were called CA-MRSA (community-
associated methicillin-resistant S. aureus) to distinguish
them from HA-MRSA. Generally HA-MRSA strains are2 International Journal of Microbiology
resistant to other antibiotics diﬀerent from β-lactams,
whereas CA-MRSA are mostly resistant to methicillin only.
HA-MRSA isolates frequently harbor SSCmec types-I, II and
III whereas CA-MRSA strains carry types IV, V, VI and VII.
Finally, unlike HA-MRSA, the majority of CA-MRSA strains
carry the lukS-F genes which code for the Panton-Valentine
leukocidin (PVL) [9, 16].
Previously, Ma et al. [17] reported the results of a CA-
MRSA outbreak that took place in Uruguay between 2002-
2003. The cases informed in this study were observed in
children, young adults and inmates. Boils and abscesses were
the most prevalent infections, followed by hidradenitis and
cellulitis.
The aim of this study was to establish the phenotypic
and genotypic characteristics of CA-MRSA strains recovered
from skin and soft-tissues infections.
2.MaterialsandMethods
We analyzed 213 S. aureus strains obtained between Decem-
ber 2004 and November 2005 from 213 outpatients with
skin and soft-tissue infections (SSTI). These strains were
recovered from four diﬀerent laboratories, three of them
located in Montevideo and the metropolitan area and the
other located 400Km from Montevideo.
Clinically and epidemiologically relevant information
from each patient were collected from the medical records
and patient interviews. Susceptibility to antimicrobial agents
was determined by the disk diﬀusion method in accordance
with the Clinical and Laboratory Standards Institute guide-
lines [18]. The antibiotics tested included oxacillin, cefoxitin,
ciproﬂoxacin, tetracycline, gentamicin, rifampin, trimetho-
prim/sulfamethoxazole, chloramphenicol, vancomycin, ery-
thromycin, and clindamycin (Oxoid Ltd., Basingstoke,
Hampshire, UK). S. aureus strain ATCC 25923 was used as
qualitycontrol.Thedoublediskdiﬀusiontestwasperformed
to determine inducible clindamycin resistance (iMLSB)[ 18].
Susceptibility to mupirocin and fusidic acid was also
tested by the disk diﬀusion method. Results were interpreted
according to Fuchs et al. [19] and to the French standards for
mupirocin and fusidic acid, respectively [20].
MICs to oxacillin and vancomycin were determined by
the agar dilution method [18].
Ninety out of the 213 strains were deﬁned as CA-
MRSA based on the epidemiologic analysis of the patients
[21] and their antibiotic susceptibility proﬁle: cefoxitin-
resistant and susceptible to trimethoprim/sulfamethoxazole,
ciproﬂoxacin, tetracycline and gentamicin. These 90 CA-
MRSAstrains were further analyzed as described in what
follows.
2.1. Virulence Factor Identiﬁcation. Alpha-hemolysin was
detected in accordance with the procedure described by
Cooper et al. [22] S. aureus Wood 46 strain was included
as a positive control. The presence of β-hemolysin was
ascertained by demonstration of increased hemolysis in
sheep blood agar plates incubated at 37◦C for 24 hours
and then at 4◦C for other 24 hours (heat-cold lysis). CP
typing was performed by colony immunoblot method with
CP5 and CP8-speciﬁc antibodies as described by Lee et al.
[23]. Strains showing a negative reaction to this test were
laterinvestigatedbyimmunodiﬀusion.Eachstrainwastested
at least twice and those isolates with no reaction to CP5
and CP8 antibodies were deﬁned as nontypeable (NT). The
presence of cap5 or cap8 genes in NT strains was determined
by PCR ampliﬁcation as described elsewhere [24].
2.2. Genotyping. Bacterial DNA was obtained from iso-
lated colonies using the Wizard genomic DNA prepara-
tion kit (Promega. Madison, Wis, USA) adding 20mg/mL
lysostaphin (Sigma Chemical) in the cell-lysis step [25]. The
presence of cna, mecA and lukS-lukF genes was determined
by PCR ampliﬁcation [26–28].
SCCmec typing was performed by a multiplex PCR
method only on 23 isolates belonging to group1 and on four
group 4 strains (described in what follows) [10].
2.3. Pulsed-Field Gel Electrophoresis (PFGE). DNA macrore-
striction and separation of fragments by PFGE were
conducted using standardized procedures [29]. DNA was
digestedwithSmaI(NewEnglandBiolabs).PFGEconditions
were 6V/cm at 11,3◦C for 23 hours, with pulses of 5 to 35
seconds. Electrophoresis was performed using a CHEF DR II
instrument (Bio-Rad, Hercules, Calif, USA). Band patterns
were visually interpreted following the criteria of Tenover
et al. [30].
3. Results and Discussion
The mecA gene was detected in the 90 CA-MRSA strains
analyzed. Nevertheless, 3 out of the 90 strains displayed
oxacillin inhibition zone diameters ≥13mm. These results
were similar to those described previously by other authors
regarding the best performance of cefoxitin 30μg disk versus
oxacillin 1μg disk for the screening of the MRSA phenotype
confered by the mecA gene [31, 32]. The MIC for oxacillin
of all the CA-MRSA strains ranged from 4 to 32μg/mL
with a MIC90 of 16μg/mL, which is consistent with the
heterogeneous resistance phenotype. These ﬁndings agree
withreportsshowingthatoxacillinMICofCA-MRSAstrains
are lower than the values observed for HA-MRSA isolates
[33].
Twenty-fouroutof90(26.6%)CA-MRSAstrainsshowed
inducible macrolide-lincosamide-streptogramin B (iMLSB)
resistance by the double-disk diﬀusion test. This ﬁgure is
similar to that obtained by Patel et al. [34] and, as suggested
by these authors, it might be due to the predominance
of the cassette IV in Uruguayan CA-MRSA strains [17]
which do not have the erm genes associated with inducible
MLSB phenotype. In this regard, twenty-three CA-MRSA
strains belonging to group 1 (described in what follows)
showedSSCmec type-IV,whereasfourgroup4strainscarried
SCCmec elements type-II.
Two isolates were resistant to chloramphenicol and
rifampin. Rifampin has a potent antistaphylococcal activity,International Journal of Microbiology 3
Table 1: Phenotypic and genotypic characteristics of CA-MRSA isolates recovered in Uruguay between 2004-2005. CP, capsular
polysaccharide; iMLB, inducible macrolide-lincosamide-streptogramin B resistance; PVL, Panton-Valentine leukocidin.
Group PFGE type CP iMLSB Phenotype PVL Number of strains
1A 8 − +6 2 (a),(b)
2A , A 1 , A 2 8 + + 1 9
3A 3 8 −−1
4B 8 + +4 (c)
5C 8 − +1
6D 8 − +1
7E N T+ − 1(d)
8F 5 −−1
Total 90
(a)Fifty-nine isolates showed positive result by colony immunoblot method with CP8 antibody and 3 strains showed positive result by PCR for the cp8 gene.
(b)Twenty-three strains showed SCCmec type-IV. (c)All strains in this group showed SCCmec type-II. (d)Positive PCR ampliﬁcation for the cp8 gene.
however resistance develops invariably when it is used as
monotherapy for the treatment of S. aureus infections. Three
of the 90 strains were resistant to mupirocin whereas all
strains were susceptible to fusidic acid. These results suggest
that fusidic acid could be used as a topical empiric adjuvant
treatment for nasal eradication of CA-MRSA.
All of the CA-MRSA strains studied were susceptible to
vancomycin by the disk diﬀusion test and displayed MICs of
≤2μg/mL.
All the CA-MRSA isolates produced α-hemolysin but
none produced β-hemolysin.
Eighty-ﬁve isolates expressed CP8, one was CP5-positive
and four strains were NT. Those four NT isolates carried the
cap8genes.ThislowprevalenceofCP5amongtheCA-MRSA
(1%)couldexplain,atleastpartially,theabsenceoffatalcases
observed in this group of patients [35].
Ninety-six percent of the CA-MRSA strains exhibited
positive PCR ampliﬁcation with lukS-F gene primers and
all strains yielded positive ampliﬁcation results with the
cna gene primers. PVL production has been associated
with CA-MRSA strains isolated from individuals with skin
infections and necrotizing pneumonia [28, 36]. In contrast
to CA-MRSA, HA-MRSA strains generally do not harbor the
lukS-lukF genes. Therefore, the presence of the PVL genes
emerged as a good local marker of CA-MRSA. With regard
to the cna gene, several reports have described an association
between the presence of this gene and the development of
bacteremia associated with deep tissue infection [26, 37]. In
this study we did not perform blood culture follow-up of the
patients infected with CA-MRSA strains and there is no local
information on the evolution of those infections caused by
cna negative S. aureus strains.
Six diﬀerent pulsotypes (A–F) (Figure 1(a))w e r ei d e n -
tiﬁed by PFGE. Eigthy-two of the 90 strains belonged to the
pulsotypeAgroup(Figure 1(a),lane1andTable 1);4isolates
were included in the pulsotype B, whereas C, D, E, and F
pulsotypeswererepresentedbyoneisolateeach.Threeminor
subtypes within pulsotype A (A1, A2, and A3) (Figure 1(b))
were identiﬁed according to Tenover’s criteria. Pulsotype A
isolates exhibited a band pattern identical to those isolates
identiﬁed by Ma et al. [17], being the most frequently found
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Figure 1:(a)Pulsed-ﬁeldgelelectrophoresis(PFGE)patternsofthe
SmaI-digested genomic DNA obtained from CA-MRSA isolates in
Uruguay. Lane 1, pulsotype A (strain IH 23); lane 2, pulsotype B
(strain IH 48); lane 3, pulsotype C (strain IH 46); lane 4, pulsotype
D (strain IH 7); lane 5, pulsotype E (strain IH 22) and lane 6
pulsotype F (strain IH 69). (b) Pulsed-ﬁeld gel electrophoresis
(PFGE) patterns of the SmaI-digested genomic DNA obtained from
CA-MRSA isolates in Uruguay. Lane 1, pulsotype A1 (strain IH 36);
lane 2, pulsotype A (strain IH 44); lane 3, pulsotype A2 (strain IH
9).
in Uruguay (UR06, ST30) during the 2002-2003 period.
Visually, the pulsotype A band pattern (Figure 1(a),l a n e1 )
closely resembles to a community-associated MRSA clone
reported in the South West Paciﬁc region. This ﬁnding is
similar to what was previously reported by Ribeiro et al.
[38] in Porto Alegre, Brazil, and it could be in agreement
to a regional dissemination of the Ocean` ıa Southwest Paciﬁc
Clone (OSPC).
Considering the PFGE results, inducible MLSB phe-
notype, the presence of PVL genes and the CP serotype4 International Journal of Microbiology
(Table 1), our ﬁndings suggest that several groups of CA-
MRSA strains were circulating in Uruguay during the period
of analysis. The major group (62 of the 90 strains) presented
the following characteristics: pulsotype A, CP8 and PVL.
Twenty-three of these 62 strains carried SCCmec type-IV.
This group also included three NT strains but with positive
PCR results for the cp8 gene (Table 1). These results might
be complemented by multilocus sequence typing (MLST) or
spaA-typing.
In summary, three years after of the ﬁrst ﬁnding of CA-
MRSA isolates in Uruguay these strains are still producing
SSTI, illustrating the stability over time of this emergent
pathogen, as well as its excellent adaptation to the com-
munity enviroment. The cefoxitin disk test would be more
reliable than the oxacillin disk test for the screening of the
MRSAphenotypeconferedbythemecAgeneandfusidicacid
could be used as a topical empiric adjuvant treatment for
nasal eradication of CA-MRSA. Our results also suggest that
the presence of PVL genes appear as useful local markers for
thedetectionofCA-MRSAstrains.Inthisstudyweidentiﬁed
three major groups of CA-MRSA strains (1, 2, and 4) deﬁned
according to phenotypic and genotypic characteristics. The
most frequent group, G1, showed a PFGE pattern identical
to CA-MRSA strains previously isolated in Uruguay and
Brazil.
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